# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-23-048961
Filing Date
2023-04-24
Accepted
2023-04-24 16:04:21
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm232000d3_ars.pdf | ARS | 2880345
| Complete submission text file | 0001104659-23-048961.txt |  | 3968508

Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39264 | Film No.: 23840022
SIC: 2834 Pharmaceutical Preparations